Classe 1958, medico chirurgo formatosi all’Università di Pavia, è specializzato in Ematologia e in Oncologia. Dopo varie esperienze lavorative e professionali, dal settembre 2010 è direttore della struttura complessa Oncologia della Fondazione IRCCS Policlinico S. Matteo di Pavia. È autore di circa 110 pubblicazioni su riviste recensite, è membro di numerose società scientifiche e ha partecipato come relatore a numerosi congressi nazionali e internazionali.
%22%20transform%3D%22translate(.7%20.7)%20scale(1.36719)%22%20fill-opacity%3D%22.5%22%3E%3Cellipse%20fill%3D%22%237ec9ff%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-85.23262%20-76.38518%2045.00476%20-50.21752%20221%20137)%22%2F%3E%3Cellipse%20fill%3D%22%233a3126%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(-99.3%2056.1%206)%20scale(255%2051.05812)%22%2F%3E%3Cellipse%20fill%3D%22%239e8f8b%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-31.4437%20-2.27124%203.62617%20-50.20186%20100.9%2088.7)%22%2F%3E%3Cellipse%20fill%3D%22%2300264d%22%20cx%3D%22156%22%20cy%3D%2212%22%20rx%3D%22255%22%20ry%3D%2217%22%2F%3E%3Cellipse%20fill%3D%22%2300458c%22%20cx%3D%229%22%20cy%3D%2255%22%20rx%3D%2232%22%20ry%3D%2280%22%2F%3E%3Cellipse%20fill%3D%22%2370a7f8%22%20cx%3D%22248%22%20cy%3D%22134%22%20rx%3D%2285%22%20ry%3D%2277%22%2F%3E%3Cellipse%20fill%3D%22%234c3725%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-22.28644%20-30.18114%2035.315%20-26.0774%2088.7%2015.8)%22%2F%3E%3Cellipse%20fill%3D%22%233372bf%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-13.14604%2022.49675%20-95.72464%20-55.93696%20242.5%2079.2)%22%2F%3E%3Cellipse%20fill%3D%22%23897460%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(4.56736%20-25.9028%2042.69941%207.52906%2021.7%20166.4)%22%2F%3E%3Cellipse%20fill%3D%22%2351453f%22%20cx%3D%22102%22%20cy%3D%22151%22%20rx%3D%2244%22%20ry%3D%2236%22%2F%3E%3Cellipse%20fill%3D%22%235486c0%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(16.53093%20-3.5969%2017.57395%2080.76785%20146.3%20123)%22%2F%3E%3Cellipse%20fill%3D%22%230e598a%22%20cx%3D%22230%22%20cy%3D%2212%22%20rx%3D%22102%22%20ry%3D%2240%22%2F%3E%3Cellipse%20fill%3D%22%236085ff%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(102.4%2080.6%20148.5)%20scale(23.59168%2050.46973)%22%2F%3E%3Cellipse%20fill%3D%22%23483f3c%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-33.50134%2039.4233%20-15.20145%20-12.91798%2044.8%20121.4)%22%2F%3E%3Cellipse%20fill%3D%22%23888587%22%20cx%3D%22104%22%20cy%3D%2272%22%20rx%3D%2223%22%20ry%3D%2244%22%2F%3E%3Cellipse%20fill%3D%22%237cb7d5%22%20cx%3D%22211%22%20cy%3D%22165%22%20rx%3D%2249%22%20ry%3D%2249%22%2F%3E%3Cellipse%20fill%3D%22%2300102a%22%20cx%3D%2252%22%20rx%3D%2241%22%20ry%3D%2219%22%2F%3E%3Cellipse%20fill%3D%22%237cb4eb%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(3.17976%20-21.05955%2034.18392%205.1614%20179.7%2095.3)%22%2F%3E%3Cellipse%20fill%3D%22%234f88ad%22%20cx%3D%22189%22%20cy%3D%2259%22%20rx%3D%2267%22%20ry%3D%2217%22%2F%3E%3Cellipse%20fill%3D%22%23636060%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(6.17368%2010.21502%20-35.14666%2021.24167%2099.3%2045.2)%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
%22%20transform%3D%22translate(.7%20.7)%20scale(1.36719)%22%20fill-opacity%3D%22.5%22%3E%3Cellipse%20fill%3D%22%23dcdcdc%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-77.2619%20228.00238%20-47.74793%20-16.18008%20214.5%20147.2)%22%2F%3E%3Cellipse%20fill%3D%22%23191919%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-128.27009%20220.39007%20-59.78553%20-34.796%2036.1%2068.4)%22%2F%3E%3Cellipse%20fill%3D%22%23dbdbdb%22%20cx%3D%22237%22%20cy%3D%22166%22%20rx%3D%2239%22%20ry%3D%2239%22%2F%3E%3Cellipse%20fill%3D%22%23909090%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-19.38936%20-9.43524%2087.37369%20-179.55244%20178%2089)%22%2F%3E%3Cellipse%20fill%3D%22%23565656%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(86.67196%20-145.16066%2019.79315%2011.81802%20125.9%2076.6)%22%2F%3E%3Cpath%20fill%3D%22%23838383%22%20d%3D%22M137%20196l70-129L81%20168z%22%2F%3E%3Cpath%20fill%3D%22%237c7c7c%22%20d%3D%22M-8.6%2097.1l1.3-37%2020%20.8-1.4%2037z%22%2F%3E%3Cellipse%20fill%3D%22%23606060%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(152.9%2040%2072)%20scale(40.67907%2025.11614)%22%2F%3E%3Cpath%20fill%3D%22%23727272%22%20d%3D%22M173%20110l25-15V47z%22%2F%3E%3Cellipse%20fill%3D%22%235f5f5f%22%20cx%3D%22140%22%20cy%3D%2260%22%20rx%3D%2229%22%20ry%3D%2233%22%2F%3E%3Cpath%20fill%3D%22%23aaa%22%20d%3D%22M145%20159.5l-4.4%208%2025.6-19.1L147%20197z%22%2F%3E%3Cpath%20fill%3D%22%239e9e9e%22%20d%3D%22M159%20197L271%2080l-41-96z%22%2F%3E%3Cpath%20fill%3D%22%233e3e3e%22%20d%3D%22M11%2029h42v153H11z%22%2F%3E%3Cpath%20fill%3D%22%23828282%22%20d%3D%22M187%2039.6L225%208l-21.2-24-40.3%2073.2z%22%2F%3E%3Cellipse%20fill%3D%22%23878787%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(10.37601%205.26952%20-11.35354%2022.3558%20110.3%20162.1)%22%2F%3E%3Cpath%20fill%3D%22%235f5f5f%22%20d%3D%22M76%20110h18v72H76z%22%2F%3E%3Cpath%20fill%3D%22%233e3e3e%22%20d%3D%22M50.4%2069.5L-16%204l140.2-20%2029.6%2030.5z%22%2F%3E%3Cpath%20fill%3D%22%237e7e7e%22%20d%3D%22M139%20128l24%2023%2037-91z%22%2F%3E%3Cellipse%20fill%3D%22%233e3e3e%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-8.84024%2044.64647%20-21.36774%20-4.23093%2092.1%2054)%22%2F%3E%3Cpath%20fill%3D%22%23606060%22%20d%3D%22M152%2097l-27-69-24%2082z%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
Tutti gli articoli
Tumore / L’esperto: vi spiego cos’è il Brca1, il gene per cui Angelina Jolie ha rinunciato al seno
Angelina Jolie ha annunciato di essersi sottoposta a un "una doppia mastectomia preventiva" per scongiurare l’insorgere di un tumore al ...
DOPING SCHWAZER/ L’esperto: ecco cos’è l’Epo e cosa si rischia a usarlo
Il caso Schwazer ha riportato alla ribaltata l'Epo come sostanza dopante. PAOLO PEDRAZZOLI, ematologo ed oncologo al San Matteo di ...
